Prevalence of antibiotic resistance in US hospitals

Diagnostic Microbiology and Infectious Disease
John EdelsbergDavid J Weber

Abstract

The percentage of isolates resistant to essential antibiotics among clinically significant bacterial pathogens was evaluated using data from 80089 qualifying admissions in 19 US hospitals (2007-2010). Percentage resistant was highest for the following pathogen/antibiotic pairs: Enterococcus faecium/vancomycin (87.1% [95% CI 86.0-88.1] of 4024 isolates), Staphylococcus aureus/oxacillin-methicillin (56.8% [56.1-57.4] of 23477 isolates), S. aureus/clindamycin (39.7% [39.1-40.4] of 21133 isolates), Pseudomonas aeruginosa/fluoroquinolones (32.6% [31.8-33.5] of 10982 isolates), and Escherichia coli/fluoroquinolones (31.3% [30.8-31.8] of 30715 isolates). The percentage resistant was 3.9% (3.2-4.9) for E. faecium/daptomycin (n = 2029 isolates). While these results are consistent with those from earlier studies in many respects, the percentage of E. faecium isolates resistant to daptomycin, while still small, is higher than has been reported to date.

References

Oct 24, 2002·Archives of Internal Medicine·Yehuda CarmeliMatthew Samore
Apr 9, 2005·The New England Journal of Medicine·Scott K FridkinUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Oct 25, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alicia I HidronUNKNOWN Participating National Healthcare Safety Network Facilities
Feb 18, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Michael R Mulvey, Andrew E Simor
Jun 9, 2009·Diagnostic Microbiology and Infectious Disease·Ronald N JonesKatsunori Yanagihara
Oct 29, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ebbing LautenbachMyoung Kim
Nov 17, 2009·Diagnostic Microbiology and Infectious Disease·David J FarrellRonald N Jones
Jul 9, 2011·International Journal of Antimicrobial Agents·Ronald N MasterJose M Bordon
Jan 19, 2012·Antimicrobial Agents and Chemotherapy·Guillermo V SanchezJose M Bordon
Dec 12, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Dawn M SievertUNKNOWN National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities

❮ Previous
Next ❯

Citations

Jun 19, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pai-Wei SuLi-Yeh Chuang
Feb 3, 2016·Infectious Diseases and Therapy·Karrine D BradeMichael J Rybak
Dec 6, 2014·Enfermedades infecciosas y microbiología clínica·Juan-Ignacio Alós
Mar 5, 2016·Expert Opinion on Investigational Drugs·Martino Maria Zacchè, Ilias Giarenis
May 1, 2015·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Vanessa CabralMaria-José U Ferreira
May 18, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D Rodriguez-PardoB Almirante
Jun 16, 2016·Frontiers in Microbiology·Ana M Guzman PrietoRob J L Willems
Sep 24, 2016·Pharmaceuticals·Nermina Malanovic, Karl Lohner
Oct 31, 2016·Journal of Ethnopharmacology·Angel V Contreras CárdenasHoracio Bach
May 7, 2015·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Alexander LangermanDavid O Meltzer
Feb 15, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Ewa SadowyWaleria Hryniewicz
Jun 30, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Dorottya FranyóZsuzsanna Dombrádi
Apr 4, 2018·JPEN. Journal of Parenteral and Enteral Nutrition·Manpreet S MundiRyan T Hurt
Aug 17, 2018·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Megan SchechtmanMichelle L Macy
Oct 27, 2016·Current Opinion in Infectious Diseases·Heather Isenman, Dale Fisher
Jan 1, 2015·Healthcare·Rodney R Dietert, Janice M Dietert
Jun 3, 2018·Pediatrics in Review·Devlynne S Ondusko, Dawn Nolt
Jan 15, 2016·The Pediatric Infectious Disease Journal·Beatriz LarruJeffrey S Gerber
Nov 1, 2014·Microbiology Spectrum·Krista Dubin, Eric G Pamer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.